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Shared decision making in health care
can be defined as the process of ‘‘…defin-
ing problems, presenting options, and
providing high-quality information so
patients can participate more actively in
care…’’ [1]. This model of decision
making is rooted in several core principles
of medical ethics, but perhaps most
strongly that of patient autonomy [2].
Autonomy—the right to self-determina-
tion—entails a process of informed and
meaningful consent to the care a patient is
to receive [3]. The idea of informed
consent clearly goes beyond a simple
procedure of form-filling, and requires
that the nature of an intervention, the
potential alternatives, the likely risks and
benefits, and the implications are clearly
laid out and mutually understood before a
patient and clinician can agree on the
course of action to be undertaken. In a
Policy Forum published in PLoS Medicine,
Michael Wilkes and Margaret Johns set
out four key characteristics of the types of
decisions that best lend themselves to
shared decision making [4]: those where
‘‘effectiveness of the outcome is uncertain;
…where the risks and benefits are sizeable
or nearly equal; …where the patient is
able and willing to participate; …[and]
where the patient can understand the
trade-offs.’’ An obvious requirement for
the fourth characteristic—the understand-
ing of trade-offs—is that a patient inter-
prets data regarding risk and can integrate
that data into their own system of values—
an issue we discuss within this Editorial.
Indeed, very many common decisions
would fit Wilkes and Johns’ criteria for
shared decision making. In such contexts,
decision aids may help patients weigh up
the factors that bear upon different
treatment options. For example, a ran-
domized trial [5] evaluated the effects of a
visual ‘‘decision board,’’ presenting the
available treatment options, adverse ef-
fects, and effects of different treatments on
survival and quality of life for women with
early-stage breast cancer. In the trial, the
board increased women’s knowledge of
treatment options, and reduced ‘‘decision-
al conflict’’ (or personal uncertainty in the
decision). Similarly, systematic reviews of
trials evaluating decision aids in general
have concluded that such tools ‘‘…do a
better job than usual care interventions in
improving people’s knowledge regarding
options, reducing their decisional conflict
related to feeling uninformed and unclear
about personal values, decreasing the
proportion of people remaining undecid-
ed, and stimulating people to take a more
active role…’’ [6]. Decision aids such as
those described therefore seem to provide
a valuable route towards the desired goal
of more fully informed consent, and a
shared decision making process.
A key challenge, however, to the
premise of shared decision making is the
observation that a patient’s choice of their
preferred treatment will change depending
on the way that key data are presented. For
example, survival data can be represented
in a ‘‘positive frame’’—chance of surviv-
al—or a ‘‘negative frame’’—chance of
dying. A patient’s choice regarding treat-
ment options will change, depending on
which type of presentation is given, even if
the actual data are equivalent [7]. How-
ever, little research has been done to
explore the dependencies between the
way that key statistics are presented, and
a patient’s choice in relation to their own
prior values.
In this issue of PLoS Medicine, we publish
two papers reporting results of Internet-
based randomized trials that investigate
which types of presentation help people to
make decisions most consistent with their
own values [8,9]. In one study [8], a trial
randomizing 2,978 participants to view six
alternative presentations of the likely re-
duction in risk of coronary heart disease
when taking statins, Cheryl Carling and
colleagues report that some ways of pre-
senting quantitative data—for example,
framing outcomes in terms of relative risk
reduction—resulted in higher numbers of
participants indicating that they would
choose to take the preventive intervention.
This effect held irrespective of a partici-
pant’s prior values. For example, partici-
pants who did not place high importance
on the prevention of coronary heart disease
could still be ‘‘persuaded’’ to take statins
when they were given data in the form of a
relative risk reduction statistic. However,
participants who were less concerned about
potentially having coronary heart disease
were still less likely to choose statins. The
relationship between a participant’s values
and their decision to take statins was found
to be similar for all ways of presenting risk
evaluated in this study. Therefore, Carling
and colleagues suggest that natural fre-
quencies are the most appropriate tool to
use in presenting this type of data, given
that participants reported these as easiest to
understand and that they gave participants
the most confidence in their decision.
The researchers also conducted a sep-
arate trial evaluating participants’ deci-
sions as to whether to visit the doctor for
an antibiotic prescription for sore throat
[9]. In this trial, 1,760 people saw four
different graphical displays representing
the effects of antibiotics on the symptoms
of sore throat, or no information. The
results of the trial suggest that bar graphs,
showing the likely duration of symptoms,
helped participants make the decisions
most consistent with their values, and
were most often preferred. Both trials
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change, their decision will also change.
It is clear from these studies, and from
systematic reviews of ‘‘information fram-
ing’’ that there is the potential for shared
decision making to be biased through the
adoption of more persuasive presenta-
tions—such as relative statistics. As a
result, the underlying principle of shared
decision making—that of empowering
patients to make decisions most compati-
ble with their values—can be undermined.
However, the two trials published in this
issue of PLoS Medicine do suggest that
certain ways of framing information—
such as the use of natural frequencies—
can be adopted that are both readily
understandable by participants and con-
sistent with their values. Moreover, these
studies illustrate how difficult it can be to
generate reliable evidence on the ways in
which people make real-life decisions: both
trials found recruitment difficult, and both
explore hypothetical scenarios rather than
actual decision making in a health care
context by patients. In real life, the
decisions that need to be made are
perhaps not as straightforward as those
evaluated by Carling and colleagues. Solid
evidence on likely outcomes of different
treatment options may not exist, and even
high-quality quantitative evidence is but
one factor within the emotional, social,
and cultural context of shared decision
making [1,10]. Trials such as those
discussed here may provide evidence
regarding the most appropriate method
for presenting data in an unbiased way to
patients. But in order for shared decision
making to support patient autonomy,
health care providers must recognize the
role of their own values and understand
and respect those of the patient, in the
decision that is ultimately made.
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